160 related articles for article (PubMed ID: 12799381)
1. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule.
Ngamkitidechakul C; Warejcka DJ; Burke JM; O'Brien WJ; Twining SS
J Biol Chem; 2003 Aug; 278(34):31796-806. PubMed ID: 12799381
[TBL] [Abstract][Full Text] [Related]
2. Functional implications of the modeled structure of maspin.
Fitzpatrick PA; Wong DT; Barr PJ; Pemberton PA
Protein Eng; 1996 Jul; 9(7):585-9. PubMed ID: 8844830
[TBL] [Abstract][Full Text] [Related]
3. Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level.
Khanaree C; Chairatvit K; Roytrakul S; Wongnoppavich A
Oncol Res; 2013; 20(9):427-35. PubMed ID: 23924927
[TBL] [Abstract][Full Text] [Related]
4. mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.
Zhang M; Sheng S; Maass N; Sager R
Mol Med; 1997 Jan; 3(1):49-59. PubMed ID: 9132279
[TBL] [Abstract][Full Text] [Related]
5. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human maspin, a serpin with antitumor properties: reactive center loop of maspin is exposed but constrained.
Al-Ayyoubi M; Gettins PG; Volz K
J Biol Chem; 2004 Dec; 279(53):55540-4. PubMed ID: 15501821
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin.
Pemberton PA; Wong DT; Gibson HL; Kiefer MC; Fitzpatrick PA; Sager R; Barr PJ
J Biol Chem; 1995 Jun; 270(26):15832-7. PubMed ID: 7797587
[TBL] [Abstract][Full Text] [Related]
8. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix.
Ngamkitidechakul C; Burke JM; O'Brien WJ; Twining SS
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3135-41. PubMed ID: 11726614
[TBL] [Abstract][Full Text] [Related]
9. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen.
Blacque OE; Worrall DM
J Biol Chem; 2002 Mar; 277(13):10783-8. PubMed ID: 11788595
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast.
Lele SM; Graves K; Gatalica Z
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):32-6. PubMed ID: 10937046
[TBL] [Abstract][Full Text] [Related]
12. Maspin is physically associated with [beta]1 integrin regulating cell adhesion in mammary epithelial cells.
Cella N; Contreras A; Latha K; Rosen JM; Zhang M
FASEB J; 2006 Jul; 20(9):1510-2. PubMed ID: 16720730
[TBL] [Abstract][Full Text] [Related]
13. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
14. Maspin inhibits cell migration in the absence of protease inhibitory activity.
Bass R; Fernández AM; Ellis V
J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513
[TBL] [Abstract][Full Text] [Related]
15. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
Sheng S; Truong B; Fredrickson D; Wu R; Pardee AB; Sager R
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):499-504. PubMed ID: 9435220
[TBL] [Abstract][Full Text] [Related]
16. Maspin sensitizes breast carcinoma cells to induced apoptosis.
Jiang N; Meng Y; Zhang S; Mensah-Osman E; Sheng S
Oncogene; 2002 Jun; 21(26):4089-98. PubMed ID: 12037665
[TBL] [Abstract][Full Text] [Related]
17. Selective conservation of the RSL-encoding, proteinase inhibitory-type, clade L serpins in Caenorhabditis species.
Luke CJ; Pak SC; Askew DJ; Askew YS; Smith JE; Silverman GA
Front Biosci; 2006 Jan; 11():581-94. PubMed ID: 16146754
[TBL] [Abstract][Full Text] [Related]
18. Simple modifications of the serpin reactive site loop convert SCCA2 into a cysteine proteinase inhibitor: a critical role for the P3' proline in facilitating RSL cleavage.
Luke C; Schick C; Tsu C; Whisstock JC; Irving JA; Brömme D; Juliano L; Shi GP; Chapman HA; Silverman GA
Biochemistry; 2000 Jun; 39(24):7081-91. PubMed ID: 10852705
[TBL] [Abstract][Full Text] [Related]
19. A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge.
Sheng S
J Cell Physiol; 2006 Dec; 209(3):631-5. PubMed ID: 17001674
[TBL] [Abstract][Full Text] [Related]
20. Production, purification, and characterization of recombinant maspin proteins.
Sheng S; Pemberton PA; Sager R
J Biol Chem; 1994 Dec; 269(49):30988-93. PubMed ID: 7983035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
